242 related articles for article (PubMed ID: 28508462)
1. Role of diffusion-weighted imaging in distinguishing thoracoabdominal neuroblastic tumours of various histological types and differentiation grades.
Wen Y; Peng Y; Duan XM; Zhang N
J Med Imaging Radiat Oncol; 2017 Dec; 61(6):718-724. PubMed ID: 28508462
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Value of Diffusion-Weighted MRI for Tumor Characterization, Differentiation and Monitoring in Pediatric Patients with Neuroblastic Tumors.
Neubauer H; Li M; Müller VR; Pabst T; Beer M
Rofo; 2017 Jul; 189(7):640-650. PubMed ID: 28511265
[No Abstract] [Full Text] [Related]
3. Diffusion weighted imaging in differentiating malignant and benign neuroblastic tumors.
Serin HI; Gorkem SB; Doganay S; Cıracı S; Unal E; Guzel M; Kucuk A; Kurtsoy A; Coskun A
Jpn J Radiol; 2016 Sep; 34(9):620-4. PubMed ID: 27418194
[TBL] [Abstract][Full Text] [Related]
4. Feasibility and possible value of quantitative semi-automated diffusion weighted imaging volumetry of neuroblastic tumors.
Gassenmaier S; Tsiflikas I; Fuchs J; Grimm R; Urla C; Esser M; Maennlin S; Ebinger M; Warmann SW; Schäfer JF
Cancer Imaging; 2020 Dec; 20(1):89. PubMed ID: 33334369
[TBL] [Abstract][Full Text] [Related]
5. Cytopathological spectrum of peripheral neuroblastic tumours in fine needle aspiration cytology and categorisation as per International Neuroblastoma Pathology Classification.
Koshy A; Jain R; Srinivasan R; Bhatia P; Kakkar N; Rajwanshi A; Gupta N; Dey P; Trehan A; Bansal D
Cytopathology; 2019 Nov; 30(6):634-643. PubMed ID: 31231909
[TBL] [Abstract][Full Text] [Related]
6. Quantitative DWI predicts event-free survival in children with neuroblastic tumours: preliminary findings from a retrospective cohort study.
Peschmann AL; Beer M; Ammann B; Dreyhaupt J; Kneer K; Beer AJ; Beltinger C; Steinbach D; Cario H; Neubauer H
Eur Radiol Exp; 2019 Jan; 3(1):6. PubMed ID: 30701332
[TBL] [Abstract][Full Text] [Related]
7. Brain lipid-binding protein: a marker of differentiation in neuroblastic tumors.
Retrosi G; Sebire NJ; Bishay M; Kiely EM; Anderson J; De Coppi P; Resca E; Rampling D; Bier N; Mills K; Eaton S; Pierro A
J Pediatr Surg; 2011 Jun; 46(6):1197-200. PubMed ID: 21683222
[TBL] [Abstract][Full Text] [Related]
8. Diffusion-weighted MRI for differentiation of neuroblastoma and ganglioneuroblastoma/ganglioneuroma.
Gahr N; Darge K; Hahn G; Kreher BW; von Buiren M; Uhl M
Eur J Radiol; 2011 Sep; 79(3):443-6. PubMed ID: 20462716
[TBL] [Abstract][Full Text] [Related]
9. Whole-tumor radiomics analysis of T2-weighted imaging in differentiating neuroblastoma from ganglioneuroblastoma/ganglioneuroma in children: an exploratory study.
Wang H; Chen X; Yu W; Xie M; Zhang L; Ding H; Li T; Qin J; He L
Abdom Radiol (NY); 2023 Apr; 48(4):1372-1382. PubMed ID: 36892608
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of benign neuroblastic tumors: Is surgery always necessary?
Whitlock RS; Mehl SC; Larson SK; Foster JH; Hicks J; Nuchtern JG; Sher AC; Vasudevan SA; Naik-Mathuria B
J Pediatr Surg; 2022 Aug; 57(8):1538-1543. PubMed ID: 34281709
[TBL] [Abstract][Full Text] [Related]
11. [Clinicopathologic features of peripheral neuroblastic tumors].
Yang BF; Fu LB; He LJ
Zhonghua Bing Li Xue Za Zhi; 2013 May; 42(5):305-10. PubMed ID: 24004586
[TBL] [Abstract][Full Text] [Related]
12. A Preliminary Study on the Application of Contrast-Enhanced Ultrasonography in Children With Peripheral Neuroblastic Tumors.
Wang T; Han D; Xiao H; Yang H; Chen JY; Tang Y
Ultrasound Med Biol; 2024 Jun; 50(6):954-960. PubMed ID: 38575414
[TBL] [Abstract][Full Text] [Related]
13. International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
Shimada H; Umehara S; Monobe Y; Hachitanda Y; Nakagawa A; Goto S; Gerbing RB; Stram DO; Lukens JN; Matthay KK
Cancer; 2001 Nov; 92(9):2451-61. PubMed ID: 11745303
[TBL] [Abstract][Full Text] [Related]
14. Utility of Phox2b immunohistochemical stain in neural crest tumours and non-neural crest tumours in paediatric patients.
Warren M; Matsuno R; Tran H; Shimada H
Histopathology; 2018 Mar; 72(4):685-696. PubMed ID: 28986989
[TBL] [Abstract][Full Text] [Related]
15. Characteristics and management of ganglioneuroma and ganglioneuroblastoma-intermixed in children and adolescents.
Alexander N; Sullivan K; Shaikh F; Irwin MS
Pediatr Blood Cancer; 2018 May; 65(5):e26964. PubMed ID: 29369484
[TBL] [Abstract][Full Text] [Related]
16. Extra-adrenal peripheral neuroblastic tumors: A clinicopathological study of 18 cases.
Shankaralingappa S; Patra S; Gami A; Trivedi P; Chalaliya AK
Indian J Pathol Microbiol; 2023; 66(2):278-285. PubMed ID: 37077068
[TBL] [Abstract][Full Text] [Related]
17. Retrospective accuracy analysis of MRI based lesion size measurement in neuroblastic tumors: which sequence should we choose?
Gassenmaier S; Tsiflikas I; Maennlin S; Urla C; Warmann SW; Schaefer JF
BMC Med Imaging; 2020 Sep; 20(1):105. PubMed ID: 32912148
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: a report from the CCG and COG.
Okamatsu C; London WB; Naranjo A; Hogarty MD; Gastier-Foster JM; Look AT; LaQuaglia M; Maris JM; Cohn SL; Matthay KK; Seeger RC; Saji T; Shimada H
Pediatr Blood Cancer; 2009 Oct; 53(4):563-9. PubMed ID: 19530234
[TBL] [Abstract][Full Text] [Related]
19. An ultrastructural and immunohistochemical evaluation of cytodifferentiation in neuroblastic tumors.
Hachitanda Y; Tsuneyoshi M; Enjoji M
Mod Pathol; 1989 Jan; 2(1):13-9. PubMed ID: 2922387
[TBL] [Abstract][Full Text] [Related]
20. High Oct4 expression: implications in the pathogenesis of neuroblastic tumours.
Monferrer E; Burgos-Panadero R; Blanquer-Maceiras M; Cañete A; Navarro S; Noguera R
BMC Cancer; 2019 Jan; 19(1):1. PubMed ID: 30606139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
